Granexin® gel (200 μM)
2019-BURN-01
Phase 2 small_molecule terminated
Quick answer
Granexin® gel (200 μM) for Second Degree Burn is a Phase 2 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- UNITED THERAPEUTICS Corp
- Indication
- Second Degree Burn
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated